RECORDED SEMINARS

Recorded Seminar

FDA Inspections, Warning Letters, & CAPA 2015 Update

timelapse 7 hrs with 30 mins of Q and A

Note:

Recorded Seminar can be played unlimited times
Along with recorded seminar, copy of presentation slides will be shared

Speaker/Presenter

J. Lawrence Stevens, RAC

FDA Regulatory Expert

Consultant, One Way Consultants, LLC

Short Abstract

This seminar will give you current excellent understanding of how FDA is working today and how assure your quality systems will meet FDA expectations.

In the areas of inspections we will explore how FDA determines which firms to inspect. What are the current driving forces for FDA inspections? What about Supply Chain issues. We will also talk about how to manage inspections in a way to minimize FDA concerns, and what to do if things are not going well during the inspection.

We will review profiles of recent warning letters related to quality systems compliance. By understanding what FDA says in their Warning Letters you can address you own quality systems in a much more focused area by knowing what FDA expects. Finally we will discuss how to respond to Warning Letter and FDA-483’s

CAPA currently is the quality system that FDA is concentrating on the most. FDA’s expectations of your CAPA program are quite high, and if you just have a basic CAPA program you may not meet FDA expectations. We will talk about the “unwritten” CAPA regulations that FDA uses inspect you.

We will end the day on a high note by talking about FDA Enforcement Actions! Seriously by understanding how FDA uses their enforcement authority you can avoid being subset to one of those FDA enforcement Actions.


Get this seminar

Program Agenda

9:00 AM – 09:30 AM Breakfast + Introduction
09:30 AM - 10:30 AM Current FDA Inspection, Enforcement Trends, and Field Issues:

  • How FDA establishes inspectional priorities
  • Current Agency, CDRH, and District inspection and enforcement focus
  • Profile of recent warning letters and 483s
  • Supply chain issues
  • Other issues of present and growing concern
10:30 AM - 10:45 AM Tea/Coffee Break
10:45 AM - 12:15 PM Managing the FDA Inspection:

  • Preparing for an impending inspection
  • Assembling the team – who should be there
  • Managing documents – what needs to be available
  • Training all employees on proper inspection rules and etiquette
  • FAQs – photographs, recordings, etc.
  • What to do if something goes wrong
  • Inspection close-out and on-site agreements
12:15 PM - 01:15 PM Lunch
01:15 PM - 02:00 PM Introducing CAPA

  • Definitions and requirements: how to keep it simple
  • Key CAPA concepts and how they fit into the overall quality system
  • The relationships among risk management, CAPA, and design process
02:00 PM - 02:45 PM When to Use CAPA

  • When to initiate a CAPA
  • How to apply risk management in the CAPA process
  • Prioritization
  • Resource allocation
  • Metrics
02:45 PM - 03:00 PM PM Break
03:00 PM - 04:30 PM PM FDA’s Enforcement Actions:
  • FDA Criteria for Determining What Items to List on a 483
  • When the Agency Will Issue a Warning Letter
  • Interactive Session: How to Respond to 483s and Warning Letters
04:45 PM - 05:00 PM Q&A – Conclusion

Registration Information

  • Registration Fee : USD $299
  • For assistance on registration, please send an email to marketing@biopractice.com or
    Please call: Ph - 1-646-216-8860
Content Disclaimer

Contents in our website are from external websites. Links to and content from external website are provided for the convenience of users. Biopractice.com takes no responsibility for the content of such links and websites.

//